These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10885783)

  • 1. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response.
    Rhodes T; Stimson GV; Crofts N; Ball A; Dehne K; Khodakevich L
    AIDS; 1999; 13 Suppl A():S259-69. PubMed ID: 10885783
    [No Abstract]   [Full Text] [Related]  

  • 2. Injecting drug use and HIV infection in Asia. The Asian Harm Reduction Network.
    Crofts N; Reid G; Deany P
    AIDS; 1998; 12 Suppl B():S69-78. PubMed ID: 9679631
    [No Abstract]   [Full Text] [Related]  

  • 3. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.
    Platt L; Bobrova N; Rhodes T; Uusküla A; Parry JV; Rüütel K; Talu A; Abel K; Rajaleid K; Judd A
    AIDS; 2006 Oct; 20(16):2120-3. PubMed ID: 17053361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and AIDS in the Asia-Pacific region: an epidemiological overview.
    Dore GJ; Brown T; Tarantola D; Kaldor JM
    AIDS; 1998; 12 Suppl B():S1-10. PubMed ID: 9679623
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug problem in southeast and southwest Asia.
    Kulsudjarit K
    Ann N Y Acad Sci; 2004 Oct; 1025():446-57. PubMed ID: 15542748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstruction of subregional diffusion of HIV infection among injecting drug users in Southeast Asia: implications for early intervention.
    Stimson GV
    AIDS; 1994 Nov; 8(11):1630-2. PubMed ID: 7848607
    [No Abstract]   [Full Text] [Related]  

  • 7. The future of the HIV pandemic.
    Grassly NC; Garnett GP
    Bull World Health Organ; 2005 May; 83(5):378-82. PubMed ID: 15976879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of HIV risk-behavior and the identification of predictors for sharing injecting materials among young drug users in Prague, Czech Republic.
    Mikl J; Brůcková M; Jedlicka J; Malý M; Vyslouzilová S; Douda I; Minarík J; Smith P; DeHovitz J
    Cent Eur J Public Health; 2001 Nov; 9(4):228-35. PubMed ID: 11787253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National infection rates fail to show HIV/AIDS threat in Asia.
    AIDS Policy Law; 2001 Oct; 16(20):3. PubMed ID: 11692477
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of HIV spread among and from injecting drug users in Asia.
    Wodak A
    Dev Bull; 2000 Jun; (52):42-4. PubMed ID: 12179449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid increase in HIV rates--Orel Oblast, Russian Federation, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jul; 52(28):657-60. PubMed ID: 12869903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimethod research from targeted sampling to HIV risk environments.
    Bluthenthal RN; Watters JK
    NIDA Res Monogr; 1995; 157():212-30. PubMed ID: 8684438
    [No Abstract]   [Full Text] [Related]  

  • 15. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The difference between men and women drug users in seroconversion risk factors].
    Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
    Sidahora; 2001 Aug; ():25-6. PubMed ID: 11681272
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle exchanges do not boost drug use, study says. IDU remains major HIV risk factor.
    AIDS Alert; 2003 Sep; 18(9):112, 114. PubMed ID: 14686305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
    Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
    J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.